Gregory D. Frattini is a registered patent agent in the Intellectual Property Department of Pepper Hamilton LLP, resident in the Pittsburgh office. Dr. Frattini currently concentrates his work on patent preparation.
Dr. Frattini received his Ph.D. from the University of Rochester in synthetic organic chemistry. His studies, under the direction of Dr. Robert K. Boeckman Jr., focused on small molecule catalysis and total synthesis. Upon graduation, Dr. Frattini joined Calorics Pharmaceuticals where he worked synthesizing a small compound library for SAR studies for optimization of activity in a proprietary cell based assay, as well as synthesizing several proteomics affinity bioprobes. After leaving Calorics, Dr. Frattini spent a year at the University of California, Irvine, synthesizing latent cumate compounds that unmasked in cancer cells which, upon diffusion into, would activate modified T-cells and kill the cancer cells.